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AbStrACt
objeCtive: This study investigated the serological status of dogs living 
in a visceral leishmaniasis-endemic area and its correlation with the 
parasitological condition of the animals.
MetHoDS: Canine humoral response was evaluated using the sera of 134 
dogs by enzyme-linked immunosorbent assay and immunohistochemistry 
to detect parasites in the skin, lymph node, and spleen of the animals. The 
specific antibodies investigated were IgG, IgG1, IgG2, and IgE.
reSULtS: According to the parasitological, laboratory, and clinical findings, 
the dogs were placed into one of four groups: asymptomatic with (AP+, n = 21) 
or without (AP-, n = 36) Leishmania tissue parasitism and symptomatic with 
(SP+, n = 52) or without (SP-, n = 25) parasitism. Higher IgG and IgE levels 
were positively correlated with the infection condition and parasite load, but not 
with the clinical status. In all groups, total IgG was the predominant antibody, 
which occurred at the expense of IgG2 instead of IgG1. Most of the infected 
dogs tested positive for IgG (SP+, 98.1%; AP+, 95.2%), whereas this was not 
observed with IgE (SP+, 80.8%; AP+, 71.2%). The most relevant finding was 
the high positivity of the uninfected dogs for Leishmania-specific IgG (SP-, 
60.0%; AP-, 44.4%), IgE (SP-, 44.0%; AP-, 27.8%), IgG1 (SP-, 28.0%; AP-, 
22.2%), and IgG2 antibodies (SP-, 56.0%; AP-, 41.7%).
CoNCLUSioNS: The serological status of dogs, as determined by any class 
or subclass of antibodies, did not accurately distinguish dogs infected with 
L. (L.) infantum chagasi from uninfected animals. The inaccuracy of the 
serological result may impair not only the diagnosis, but also epidemiological 
investigations and strategies for visceral leishmaniasis control. This complex 
serological scenario occurring in a visceral leishmaniasis-endemic area highlights 
the challenges associated with canine diagnosis and points out the difficulties 
experienced by veterinary clinicians and coordinators of control programs.
DeSCriPtorS: Leishmaniasis, Visceral, diagnosis. Leishmaniasis, 
Visceral, epidemiology. Leishmania, immunology. Dogs. 
Seroepidemiologic Studies. Endemic Diseases, veterinary.
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Visceral leishmaniasis (VL) is regarded worldwide as a 
public health problem of increasing importance.15 The 
domestic dog is considered the main reservoir of the 
Leishmania pathogen, and from an epidemiological 
point of view, canine visceral leishmaniasis (canVL) 
is of considerable importance because canine disease 
precedes the occurrence of human cases, and a group 
of infected animals can serve as source of infection for 
the vector.5,7 In Brazil, the major prophylactic practi-
ces for disease control include the systematic and early 
treatment of human cases, in addition to vector control 
and elimination of seropositive dogs.15
Serology is, by far, the most commonly used diagnos-
tic tool in large surveys and in clinics. However, this 
method has been seriously criticized, as it frequently 
fails to recognize asymptomatic dogs,17 is not capable of 
differentiating infected animals from vaccinated ones,9 
reSUMo
objetivo: Foi investigado o status sorológico de cães, em área endêmica de 
leishmaniose visceral, e sua correlação com a infecção parasitológica dos animais.
MÉtoDoS:  A resposta humoral canina foi avaliada no soro de 134 cães pelo método 
ELISA e pela imuno-histoquímica, para detectar parasitos na pele, linfonodo e baço 
desses animais. Os anticorpos específicos investigados foram IgG, IgG1, IgG2 e IgE.
reSULtADoS: De acordo com os achados parasitológicos, laboratoriais e 
clínicos, os cães foram alocados em um dos quatro grupos: assintomáticos 
com (AP+, n = 21) e sem (AP-, n = 36) parasitismo tecidual por Leishmania e 
sintomáticos com (SP+, n = 52) ou sem (SP-, n = 25) parasitismo. Níveis mais 
elevados de IgG e IgE se correlacionaram positivamente com o status de infecção 
e a carga parasitária, mas não com a condição clínica. Em todos os grupos, IgG 
total foi o anticorpo predominante, com maior concentração de IgG2 que IgG1. 
O anticorpo IgG foi positivo em proporção elevada nos animais infectados (SP+ 
98,1%; AP+ 95,2%), mas não o IgE (SP+ 80,8%; AP+ 71,2%). O achado mais 
relevante refere-se aos cães não infectados que apresentaram elevada positividade 
para anticorpos IgG anti-Leishmania (SP- 60,0%; AP- 44,4%), IgE (SP- 44,0%; 
AP- 27,8%), IgG1 (SP- 28,0%; AP- 22,2%) e IgG2 (SP- 56,0%; AP- 41,7%).
CoNCLUSÕeS: O status sorológico dos cães, determinado por qualquer classe 
ou subclasse de anticorpos, não distinguiu com acurácia cães infectados por 
L. (L.) infantum chagasi daqueles não infectados. A imprecisão do resultado 
sorológico pode prejudicar não só o diagnóstico, mas também as investigações 
epidemiológicas e as estratégias para o controle da leishmaniose visceral. 
Esse complexo cenário sorológico observado na área endêmica mostra quão 
desafiador é o diagnóstico canino, e aponta a dificuldade enfrentada pelos 
médicos veterinários e coordenadores dos programas de controle.
DeSCritoreS: Leishmaniose Visceral, diagnóstico. Leishmaniose 
Visceral, epidemiologia. Leishmania, imunologia. Cães. Estudos 
Soroepidemiológicos. Doenças Endêmicas, veterinária.
iNtroDUCtioN
and frequently shows cross-reactivity with sera from 
dogs infected with other pathogens.3 Thus, the resulting 
inaccuracies in diagnosing canVL has led to unneces-
sary culling of dogs or even the maintenance of infec-
ted dogs in areas of transmission, both of which decre-
ase the effectiveness of the Brazilian control program.1
Total IgG is the only anti-Leishmania antibody that is routi-
nely inspected. Other classes and IgG subclasses of antibo-
dies have been studied; however, these effects were geared 
towards detecting markers related to clinical prognosis or 
vaccination status2,6,14 and evaluating the efficacy of treat-
ments.10,24,25 Nevertheless, the practical use and the reliabi-
lity of these markers for diagnostic purposes remain unclear.
The objective of this study was to investigate the serologi-
cal status of dogs living in an endemic area for VL and its 
correlation with the parasitological condition of the animals.
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MetHoDS
The investigation involved dogs from the municipality of 
Araçatuba, located in northwest Sao Paulo, Southeastern 
Brazil, which is a region with high endemicity for canVL 
(12.0% - 42.0%) and reported its first canine case in 1998.13
A total of 134 stray dogs were collected by the Centro de 
Controle de Zoonoses (Zoonosis Control Center) from 
the streets of Araçatuba, SP, without previous serologi-
cal inspection for leishmaniasis and ultimately destined 
to euthanasia for sanitary practices. These were male 
and female dogs between two and six years old and of 
various breeds and weights. The animals were anestheti-
zed with 25 mg/kg sodium thiopental (Cristália, Brazil), 
and blood samples were drawn by cardiac puncture. The 
sera were stored at -20°C. Necropsies were performed 
following euthanasia using potassium chloride, and popli-
teal lymph nodes and fragments of the spleen and skin 
were collected and fixed in 10.0% buffered formalin.
This study was conducted in accordance with the ethical 
principles of animal experimentation adopted by the Colégio 
Brasileiro de Experimentação Animal and was approved 
by the Ethics Committee of the Faculdade de Medicina of 
the Universidade de São Paulo, Brazil (number 706/04).
Immunohistochemistry was performed on paraffin sections 
of the popliteal lymph nodes, spleens, and skin from each 
dog.12 Briefly, paraffin-embedded sections were dewaxed 
and rehydrated. Antigen retrieval was conducted by stea-
ming the sections in a 10 mM citric acid solution (pH 6.0) 
for 30 min in a water bath at 95°C. Endogenous peroxi-
dase activity was quenched with 3.0% hydrogen peroxide, 
and unspecific interactions were blocked with a solution of 
60 g/L powdered skimmed milk diluted in distilled water. 
Immunolabeling was performed with a mouse anti-Leish-
mania polyclonal antibody diluted 1/800 in 0.01 M phos-
phate-buffered saline (PBS) containing 1.0% bovine serum 
albumin at 4°C overnight. After washing, the sections were 
incubated with a biotinylated secondary antibody and then 
with a streptavidin-peroxidase complex from the LSAB kit 
(DakoCytomation, USA). Both incubations were performed 
at 37°C for 30 min. Color development was conducted for 
five min at room temperature, using 3-3-diamenobenzidine 
(Sigma, USA) at 60 mg/100 mL 0.01 M PBS containing 
1.0% hydrogen peroxide. The sections were counterstained 
with hematoxylin, dehydrated, and mounted in resin. After 
a comparative analysis of all slides, tissue parasitism was 
considered negative (-) when the sample did not contain 
any parasites in 20 fields, low (+) when a sample contai-
ned 1-10 amastigotes/field, moderate (++) for 11-25 amas-
tigotes/field, and high (+++) for more than 25 amastigotes/
field, using the 40× objective.
To optimize the enzyme-linked immunosorbent assay 
(ELISA), we tested different concentrations of crude and 
soluble antigens of L. (L.) infantum chagasi (MHOM/
BR/72/LD46), dilutions of control positive sera with low, 
moderate, and high titers, protein A, alkaline phosphatase 
conjugate, and levels of cut-offs. After checkerboard titra-
tions, the best discriminative condition between positive 
(n = 10) and negative controls (n = 30) for each isotype 
was defined, and we performed the ELISA as follows: a 
suspension of stationary-phase promastigotes was disrup-
ted by freeze-thawing, sonicated once for 60 sec in ice bath, 
and then centrifuged at 10,000 g for 20 min. The superna-
tant was collected and microplates were coated with 10 µg/
mL of this soluble antigen in 0.1 M carbonate-bicarbonate 
buffer (pH 9.5) at 4°C overnight for IgG and with 20 µg/mL 
for IgG1, IgG2, and IgE. After blocking the wells with 
10.0% powdered skim milk in 0.01 M PBS with 0.05% 
Tween (PBS-T), 100 µL of the diluted serum samples at 
ratios of 1:400 for IgG, 1:200 for IgG1 and IgG2, and 1:20 
for IgE were added to each well and incubated at 37°C for 
2 h for IgG detection or at 4°C overnight for IgG1, IgG2, 
and IgE. After washing with PBS-T, 100 µL of alkaline 
phosphatase-labeled secondary antibodies at dilutions of 
1:2,000 for IgG, 1:500 for IgG1 and IgG2, and 1:50 for 
IgE (Bethyl Laboratories, USA) were added to each well, 
and the plates were incubated at 37°C for 1h. After further 
washing, 100 µL/well of 1.0 mg/mL pNPP (Sigma, USA) 
in 0.1 M carbonate-bicarbonate buffer pH 9.5 was added, 
and the samples were incubated for 30 min at room tem-
perature. The reaction was stopped with 50 µL/well of 1 M 
NaOH, and absorbance was measured at a wavelength of 
405 nm using an ELISA reader. The minimum level of detec-
tion (cut-off) was set at the mean optical density obtained 
from the negative controls plus three standard deviations.
To measure the amount of cross-reactivity with L. (L.) 
infantum chagasi ELISA, sera of dogs with ehrlichio-
sis (n = 17), babesiosis (n = 9), toxoplasmosis (n = 9), 
neosporosis (n = 6), Chagas disease (n = 6), toxocariasis 
(n = 9), and dirofilariasis (n = 6) were tested.
The clinical signs assessed were as follows: lymphade-
nopathy, splenomegaly, hepatomegaly, weight loss, skin 
lesions (desquamation, alopecia, ulcers, and nodules), and 
onychogryphosis. Serum biochemistry was conducted for 
all dogs. The animals were initially divided into two groups: 
symptomatic, including dogs displaying any clinical sign 
compatible with canVL and/or biochemical abnormali-
ties, and asymptomatic, composed with apparently heal-
thy animals with serum protein levels of < 8.5 mg/dL and 
serum creatinine levels within normal limits, according 
to the International Renal Interest Society (IRIS, 2006).a
Considering the parasitological, laboratory, and clinical 
findings, the animals were finally classified as follows: 
asymptomatic with (AP+) and without (AP-) detectable 
parasitism by immunohistochemistry and symptomatic with 
(SP+) or without (SP-) Leishmania visualization in tissues.
a International Renal Interest Society. IRIS guidelines [Internet]. Basel; 2006 [cited 2012 Mar]. Available from: http://www.iris-kidney.com/guidelines/
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Statistical analysis was performed with SPSS for Windows 
version 12.0. Kruskal-Wallis (Mann-Whitney Rank Sum 
test) was used to compare the anti-Leishmania antibody 
levels (optical density values) and the parasite load between 
groups. Spearman’s rank test (rs) was used to correlate 
antibody levels with the degree of tissue parasitism and 
clinical condition. The level of significance for all cases 
was set at p ≤ 0.05. Kappa test (κ) was used to quantify 
the agreement between IgG results and other isotypes.
reSULtS
Of the 134 dogs studied, 57 (42.5%) were asymptomatic 
and 77 (57.5%) were symptomatic (Table 1). The most 
frequent clinical signs in the symptomatic population 
included cutaneous lesions (84.4%), lymphadenomegaly 
(76.6%), splenomegaly (66.0%), weight loss (45.5%), 
onychogryphosis (28.6%), and hepatomegaly (27.3%).
Tissue parasitism was detected in 21 (36.8%) of the 
asymptomatic cases (AP+ group) and in 52 (67.5%) 
of the symptomatic dogs (SP+ group). Leishmania was 
not detected in 36 (63.2%) of the asymptomatic dogs 
(AP- group) and in 25 (32.5%) of those with clinical 
signs suggestive of canVL (SP- group) (Table 1). The 
lymph nodes were the most common positive site in the 
infected animals (n = 73; 100%), followed by the spleen, 
(n = 60; 82.2%), and skin (n = 47; 64.4%) (Table 2). 
The degree of parasitism in all tissues did not differ 
between AP+ and SP+ dogs (p > 0.05).
A high degree of variability in the levels of anti-Leish-
mania antibody types and subtypes was observed 
among dogs (Figure). Total IgG was the most abun-
dant Leishmania-specific antibody (optical density 
median = 0.61), followed by IgG2 (optical density 
median = 0.50), IgE (optical density median = 0.13), 
and IgG1 (optical density median = 0.11) (Figure). In 
the infected groups, 20 (95.2%) AP+ and 51 (98.1%) 
SP+ dogs tested positive for Leishmania-specific IgG 
antibodies (Table 3). In the uninfected dogs, positivity 
for Leishmania-specific IgG antibodies was observed in 
both AP- (44.4%) and SP- (60.0%) animals (Table 3). 
The results examining the IgG2 showed high agree-
ment (κ > 0.90), IgE a moderate to substantial agree-
ment (κ < 0.79), and IgG1 a fair to moderate agreement 
(κ < 0.50) with those obtained for total IgG.
With respect to IgE antibodies, 71.4% (AP+) and 80.8% 
(SP+) of the infected dogs were positive. Uninfected dogs 
also had Leishmania-specific IgE in their sera, 27.8% in 
the AP- group, and 44.0% in the SP- group (Table 3).
The levels of IgG and IgE did not significantly differ 
between the clinically symptomatic and asymptomatic 
groups (SP- versus AP-, and SP+ versus AP+; p > 0.05), 
but the infection status showed higher levels of both 
types of antibodies (p ≤ 0.05) (Figure). A correlation 
between total IgG and IgE levels (p ≤ 0.05) and the 
amount of parasitism was observed in the lymph node 
(rs = 0.62 and rs = 0.55, respectively), spleen (rs = 0.56 
and rs = 0.47, respectively), and skin (rs = 0.51 and 
rs = 0.52, respectively) and also IgG1, although in a weak 
fashion: lymph node (rs = 0.26), spleen (rs = 0.30), and 
skin (rs = 0.31). IgG2 showed no correlation.
table 3. Percentage of positive results for each type of anti-Leishmania antibody detected in dogs from an endemic area, 
according to their clinical and parasitological conditions.
Dogs
Asymptomatic Symptomatic
IgG IgG1 IgG2 IgE IgG IgG1 IgG2 IgE
 n % n % n % n % n % n % n % n %
Infected 20 95.2 13 61.9 20 95.2 15 71.4 51 98.1 37 71.2 50 96.2 42 80.8
Uninfected 16 44.4 8 22.2 15 41.7 10 27.8 15 60.0 7 28.0 14 56.0 11 44.0
table 2. Frequencies of the parasite loads in the spleen, lymph node, and skin of symptomatic (SP+) and asymptomatic (AP+) 
infected dogs in a visceral leishmaniasis-endemic area. Araçatuba, SP, Southeastern Brazil, 2006.
Dogs
Spleena Lymph nodea Skina
(+) (++) (+++) (+) (++) (+++) (+) (++) (+++)
n % n % n % n % n % n % n % n % n %
SP+ (n = 52) 16 30.8 11 21.2 14 26.9 24 46.2 10 19.2 18 34.6 9 17.3 12 23.1 15 28.9
AP+ (n = 21) 5 23.8 5 23.8 9 42.9 7 33.3 5 23.8 9 42.9 5 23.8 3 14.3 3 14.3
Total (n = 73) 21 28.8 16 21.9 23 31.5 31 42.5 15 20.5 27 37.0 14 19.2 15 20.6 18 24.7
SP+: symptomatic with parasitism dogs; AP+: asymptomatic with parasitism dogs
a Parasite load was graduated as: + low, ++ moderate and +++ high.
table 1. Absolute number and percentage of infected and 
uninfected dogs enrolled in the study, in relation to clinical 
status. Araçatuba, SP, Southeastern Brazil, 2006. (N = 134)
Clinical status
Infected Uninfected Total
n % n % n %
Asymptomatic dogs 21 36.8 36 63.2 57 42.5
Symptomatic dogs 52 67.5 25 32.5 77 57.5
Total 73 54.5 61 45.5 134 100
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Cross-reactivity with the L. (L.) infantum chagasi ELISA 
was detected with IgG antibodies present in the serum from 
two of nine animals diseased with babesiosis (22.2%), 
and with IgE from 1 out of 17 animals (5.9%) with ehr-
lichiosis, and 1 out of 9 (11.0%) with toxoplasmosis.
DiSCUSSioN
The non-specific and varied clinical manifestations of 
canVL, which can overlap with the symptoms of other 
canine infections, and the lack of external signs in the 
infected asymptomatic animals make the diagnosis 
of leishmaniasis one of the most significant problems 
concerning the disease, which in most cases may ren-
der ineffective epidemiological surveillance and VL 
control measures.24
It is clear that veterinarians and practitioners of control pro-
grams aim to diagnose a case of VL with certainty. Thus, 
we investigated the potential of employing serology for 
examining the levels and the positivity of anti-Leishmania 
IgG (total and subclasses) and IgE antibodies in a canine 
population living in a region with high canVL endemic-
ity, taking into account their parasitological condition.
This study revealed four groups of dogs living in such 
region. There were asymptomatic animals infected with 
L. (L.) infantum chagasi (AP+) or not (AP-), symptom-
atic dogs with confirmed tissue parasitism (SP+), and 
dogs presenting signs related to canVL without detect-
able Leishmania infection (SP-).
The sera of both asymptomatic and symptomatic dogs 
contained detectable levels of all antibodies inspected, 
even those without Leishmania tissue parasitism. IgG was 
by far the most predominant Leishmania-specific anti-
body and IgG2 was the major subclass present, a result 
observed in previous reports,23,25 but not by Quinnell et 
al,18 who observed high levels of Leishmania-specific 
IgG1 in sick and asymptomatic parasite-positive dogs 
compared to the uninfected ones. In our study, all four 
groups were low responders for IgG1, including the SP+ 
dogs. Although IgG1 was higher in the SP+ dogs than in 
the other groups, its level in asymptomatic infected ani-
mals (AP+) did not differ from those of the non-parasitized 
dogs, excluding its possible use for diagnostic purposes.
Few studies have assessed IgE in canVL, but some 
have shown that high IgE production in symptomatic 
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Figure. Dot-plot of the optical densities of the canine sera and the respective cut-offs for IgG, IgG1, IgG2, and IgE. 
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parasitism.6,19,20 In the present study, all groups pro-
duced small amounts of Leishmania-specific IgE anti-
bodies and were not significantly different from those of 
symptomatic dogs and their asymptomatic counterparts 
(AP- versus SP-; AP+ versus SP+), which was similar 
to the findings of Amorim et al.2 No correlation between 
the levels of both IgG and IgE and the clinical status 
was observed in the present study. However, correla-
tion between these antibodies and infection condition 
was observed, specifically with the detection of amasti-
gotes in tissues (skin, lymph nodes, or spleen), and with 
the levels of the parasite burden, which did not differ 
between the asymptomatic (AP+) and sick dogs (SP+).
In this investigation, 98.1% and 80.8% of the symp-
tomatic infected animals (SP+) tested positive for 
Leishmania-specific IgG and IgE antibodies, respec-
tively, which demonstrate that serology adequately 
reflected the Leishmania infection status of these dogs, 
especially with respect to IgG. Regarding the infected 
but asymptomatic dogs (AP+), 95.2% were positive 
for Leishmania-specific IgG, but IgE failed to detect 
28.6% of these animals. Our major concern was that a 
high percentage of the asymptomatic animals without 
Leishmania tissue parasitism (AP-) also tested positive 
for Leishmania-specific IgG (44.4%), IgG subclasses 
and IgE (27.8%). This finding may be attributable to 
recent infection without the establishment of tissue 
parasitism. Another is that these dogs have suffered a 
transient infection, characterized by initial parasitolog-
ical positivity that might have become and remained 
negative thereafter,16 and had already controlled the 
Leishmania infection at the time we performed sera col-
lection. Therefore, the Leishmania-specific antibodies 
detected in the AP- group could be the result of specific 
antibodies that were maintained in the bloodstream after 
recovery. However, cross-reactivity was not ruled out, 
which could also explain the anti-Leishmania antibod-
ies found in the SP- group, with clinical signs related 
to canVL, although proven to be Leishmania-negative.
Leishmania antigens used in serological tests are recog-
nized by antibodies present in the sera of dogs infected 
with a plethora of agents, including protozoans, bac-
teria, fungi, intestinal and non-intestinal worms, and 
ectoparasites.3,8,11,17,21,22 Among the sera we tested, 
cross-reactivity with IgG was observed in dogs with 
babesiosis, and with IgE in those with ehrlichiosis and 
toxoplasmosis. Thus, we may not exclude that SP- dogs 
were infected with other agents that can cause some 
clinical signs compatible with canVL, such as alope-
cia or desquamation, sole signs presented in a portion 
of our symptomatic population, which highlights the 
importance of conducting a differential diagnosis, as 
evidenced by others.4,24
Among the four isotypes investigated, IgG would be the 
only antibody that should be used for screening VL due 
to its high positivity in infected dogs (AP+ and SP+), 
but the overall results pointed that the use of serology 
as a sole diagnostic method is ineffective in determin-
ing if dogs are actually infected with Leishmania, thus 
requiring additional confirmatory tests.
With regard to the parasitological method used in this 
study to define infection status, immunohistochemistry 
is a technique that could provide results that were com-
parable to those obtained with conventional polymerase 
chain reaction (PCR) and is sensitive enough to detect 
low parasite load such as in samples from asymptomatic 
dogs.13 Moreover, to ensure precise immunohistochemi-
cal parasitological diagnosis, the presence of parasites 
was examined in three different tissues, namely, skin, 
spleen, and lymph nodes, which are the most likely 
sites of high parasitism during a L. (L.) infantum cha-
gasi infection.13,19 For those reasons, there is a strong 
probability that both groups in which no amastigotes 
were visualized in the tissues inspected, AP- and SP-, 
truly included only unparasitized animals.
In conclusion, we characterized the serological and 
the infection statuses of dogs living in a VL-endemic 
region and demonstrated that serology, even using an 
optimized technique with specific L. (L.) infantum 
chagasi antigens, was not reliable method for dis-
criminating between Leishmania-infected and unin-
fected dogs through any of the four isotypes tested. 
This complex serological scenario that we observed 
in the endemic area reflects the difficulties experi-
enced by veterinary clinicians and coordinators of 
control programs. Thus, to enhance the effectiveness 
of control measures, a re-evaluation of the canine 
serodiagnosis is necessary, especially in countries 
where VL is a major public health problem.
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